RhumbLine Advisers’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33K | Sell |
|
|||||
|
2025
Q1 | $80.4K | Buy |
|
|||||
|
2024
Q4 | $178K | Buy |
|
|||||
|
2024
Q3 | $303K | Buy |
|
|||||
|
2024
Q2 | $638K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $199K | Sell |
|
|||||
|
2020
Q4 | $129K | Buy |
|
|||||
|
2020
Q3 | $160K | Sell |
|
|||||
|
2020
Q2 | $855K | Buy |
|
|||||
|
2020
Q1 | $430K | Buy |
|
|||||
|
2019
Q4 | $441K | Buy |
|
|||||
|
2019
Q3 | $382K | Sell |
|
|||||
|
2019
Q2 | $546K | Buy |
|
|||||
|
2019
Q1 | $469K | Buy |
|
|||||
|
2018
Q4 | $378K | Buy |
|
|||||
|
2018
Q3 | $319K | Sell |
|
|||||
|
2018
Q2 | $230K | Buy |
|
|||||
|
2018
Q1 | $260K | Buy |
|
|||||
|
2017
Q4 | $263K | Sell |
|
|||||
|
2017
Q3 | $326K | Buy |
|
|||||
|
2017
Q2 | $283K | Buy |
|